Sofia Fund recently announced its third investment in Cognition Therapeutics, Inc. (CogRx), a Pittsburgh-based biopharmaceutical company that discovers, develops and manufactures innovative therapeutics for the treatment of Alzheimer’s disease and other neurocognitive disorders.
The Sofia Fund investment was part of Cognition Therapeutic’s most recent financing round, through which the company hopes to raise up to $5 million.…